TWD
FULC icon

True Wealth Design’s Fulcrum Therapeutics FULC Stock Holding History

True Wealth Design’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260 Buy
71
+22
+45% +$134 ﹤0.01% 2394
2026
Q1 		$376 Buy
49
+33
+206% +$306 ﹤0.01% 2151
2025
Q4 		$181 Hold
16
– – ﹤0.01% 2247
2025
Q3 		$148 Hold
16
– – ﹤0.01% 2368
2025
Q2 		$111 Buy
16
+6
+60% +$32 ﹤0.01% 2216
2025
Q1 		$29 Buy
+10
New +$37 ﹤0.01% 2518

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

True Wealth Design's FULC Position: Q2 2026 in Review

True Wealth Design increased its Fulcrum Therapeutics (FULC) stake by 45% in Q2 2026, buying an estimated $134 and bringing the position to 71 shares worth $260. The position accounts for ﹤0.01% of the portfolio, ranked #2394.

True Wealth Design first reported a position in FULC in Q1 2025 and has held it in 6 quarters since. The position peaked at $376 in Q1 2026. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • True Wealth Design held 71 shares of Fulcrum Therapeutics worth $260 as of Q2 2026.
  • True Wealth Design bought 22 Fulcrum Therapeutics shares in Q2 2026, an estimated $134.
  • Fulcrum Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2394 holding.
  • True Wealth Design first reported a position in Fulcrum Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • True Wealth Design's Fulcrum Therapeutics position peaked at $376 in Q1 2026.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.